Clinical Trials

From the advanced search, you can use the IDs below to search within the topic "Clinical Trials" (whose ID is 19), by searching on (19/0) [cluster] (replacing the "19/0" with any cluster id below)

ID	Cluster Name Click to Search	Defining Terms
19/0	Clinical Trials sub-cluster 0	pancreatic patients acute chronic amylase ercp serum pancreas patient disease
19/1	Clinical Trials sub-cluster 1	stroke patients ischemic acute strokes tia risk cerebral patient clinical
19/2	Clinical Trials sub-cluster 2	atrial fibrillation patients sinus cardioversion rhythm flutter patient paroxysmal left
19/3	Clinical Trials sub-cluster 3	hd patients hemodialysis dialysis capd pd disease huntington levels renal
19/4	Clinical Trials sub-cluster 4	seizure patients epilepsy epileptic eeg patient partial generalized onset ictal
19/5	Clinical Trials sub-cluster 5	ra patients rheumatoid arthritis disease hla controls synovial oa ras
19/6	Clinical Trials sub-cluster 6	ulcer patients duodenal ulcers peptic gastric ulceration pylori patient disease
19/7	Clinical Trials sub-cluster 7	thyroid patients thyroiditis graves disease tg iodine tsh thyroglobulin thyrotoxicosis
19/8	Clinical Trials sub-cluster 8	esophageal patients esophagitis dysphagia reflux barrett achalasia manometry symptoms swallowing
19/9	Clinical Trials sub-cluster 9	hypothyroidism patients tsh thyroid hyperthyroidism euthyroid hyperthyroid hypothyroid thyroxine t4
19/10	Clinical Trials sub-cluster 10	gastric patients emptying gastritis pylori ulcer dyspepsia stomach symptoms mucosa
19/11	Clinical Trials sub-cluster 11	af patients atrial fibrillation patient ablation rhythm paroxysmal sinus group
19/12	Clinical Trials sub-cluster 12	reflux patients oesophageal ph symptoms gastroesophageal gerd monitoring esophageal gastro
19/13	Clinical Trials sub-cluster 13	patients vt ventricular syncope tachycardia arrhythmias icd arrhythmia vf antiarrhythmic
19/14	Clinical Trials sub-cluster 14	eeg patients eegs abnormalities epilepsy patient abnormal seizures clinical epileptic
19/15	Clinical Trials sub-cluster 15	arthritis rheumatoid patient synovial disease juvenile joint psoriatic methotrexate clinical
19/16	Clinical Trials sub-cluster 16	colitis ulcerative patients uc cd crohn disease ibd bowel inflammatory
19/17	Clinical Trials sub-cluster 17	lupus sle patients erythematosus systemic disease patient nephritis clinical antiphospholipid
19/18	Clinical Trials sub-cluster 18	peritoneal dialysis peritonitis capd patient ambulatory continuous pd dialysate fluid
19/19	Clinical Trials sub-cluster 19	dialysis patients haemodialysis renal hemodialysis chronic patient esrd peritoneal disease
19/20	Clinical Trials sub-cluster 20	carotid patients endarterectomy stenosis artery stroke asymptomatic disease occlusion erectile
19/21	Clinical Trials sub-cluster 21	iron patients anemia deficiency erythropoietin anaemia ferritin epo serum patient
19/22	Clinical Trials sub-cluster 22	sclerosis ms patients multiple disease progressive patient remitting relapsing controls
19/23	Clinical Trials sub-cluster 23	patients tachycardia block av pacing conduction atrioventricular pacemaker sinus ablation
19/24	Clinical Trials sub-cluster 24	bleeding patients gastrointestinal varices endoscopy patient hemorrhage portal upper variceal
19/25	Clinical Trials sub-cluster 25	fibrosis cystic patients cf patient cfs alcoholic alcohol pulmonary disease
19/26	Clinical Trials sub-cluster 26	csf patients cerebrospinal fluid meningitis levels patient hydrocephalus disease serum
19/27	Clinical Trials sub-cluster 27	patients cholesterol ldl lipoprotein lipid hdl levels serum lp disease
19/28	Clinical Trials sub-cluster 28	hypertension patients hypertensive patient portal essential renal antihypertensive pulmonary treatment
19/29	Clinical Trials sub-cluster 29	patients valve mitral aortic endocarditis regurgitation valves patient stenosis echocardiography
19/30	Clinical Trials sub-cluster 30	spinal patients cord injury patient sci cervical lumbar vocal injured
19/31	Clinical Trials sub-cluster 31	bnp patients ml probnp nt pg levels ng natriuretic ctnt
19/32	Clinical Trials sub-cluster 32	dementia ad patients alzheimer cognitive disease demented controls mci impairment
19/33	Clinical Trials sub-cluster 33	headache migraine patients headaches patient attacks aura cluster chronic pain
19/34	Clinical Trials sub-cluster 34	crp patients il-6 levels tnf serum alpha reactive disease cytokines
19/35	Clinical Trials sub-cluster 35	cirrhosis patients ascites cirrhotic liver portal biliary hcc pbc shunt
19/36	Clinical Trials sub-cluster 36	patients vitamin hyperparathyroidism parathyroid patient calcium pth b12 serum hypercalcemia
19/37	Clinical Trials sub-cluster 37	epilepsy patients temporal lobe tle frontal seizure mri seizures hippocampal
19/38	Clinical Trials sub-cluster 38	pd patients parkinson levodopa disease tremor parkinsonism parkinsonian dopa motor
19/39	Clinical Trials sub-cluster 39	sarcoidosis patients pleural effusion pericardial effusions chest pulmonary patient fluid
19/40	Clinical Trials sub-cluster 40	hemodialysis patients chronic uremic patient dialysis maintenance undergoing term renal
19/41	Clinical Trials sub-cluster 41	patients gallbladder biliary bile stones duct cholecystectomy stone gallstones jaundice
19/42	Clinical Trials sub-cluster 42	patients bladder incontinence urinary detrusor sphincter urodynamic anal voiding urethral
19/43	Clinical Trials sub-cluster 43	patients ventricular lv left diastolic ejection systolic echocardiography echocardiographic function
19/44	Clinical Trials sub-cluster 44	liver patients hepatic disease patient cirrhosis hepatitis biopsy chronic serum
19/45	Clinical Trials sub-cluster 45	schizophrenia patients bipolar schizophrenic clozapine controls episode psychosis patient disorder
19/46	Clinical Trials sub-cluster 46	thrombosis patients venous dvt heparin pe vein deep anticoagulation thromboembolism
19/47	Clinical Trials sub-cluster 47	cardiac patient arrest disease surgery heart risk output echocardiography failure
19/48	Clinical Trials sub-cluster 48	patients ck cea ca prostate prostatic serum psa mb levels
19/49	Clinical Trials sub-cluster 49	patients trauma injury injuries head patient injured blunt severe traumatic
19/50	Clinical Trials sub-cluster 50	ventilation respiratory patients ards mechanical failure patient ventilated ventilator acute
19/51	Clinical Trials sub-cluster 51	bone patients marrow bmd disease mineral osteoporosis myeloma serum patient
19/52	Clinical Trials sub-cluster 52	hearing patients vestibular loss vertigo tinnitus ear patient sensorineural nystagmus
19/53	Clinical Trials sub-cluster 53	heart patients failure chf congestive hf patient chronic beta disease
19/54	Clinical Trials sub-cluster 54	patients burn burned burns shock septic patient oxygen ill sepsis
19/55	Clinical Trials sub-cluster 55	patients colonic colon polyps constipation colonoscopy rectal transit enema barium
19/56	Clinical Trials sub-cluster 56	patients lithium nutritional nutrition parenteral nervosa weight anorexia patient enteral
19/57	Clinical Trials sub-cluster 57	cardiomyopathy patients ecg qt hypertrophic dilated ventricular qtc st electrocardiographic
19/58	Clinical Trials sub-cluster 58	leukemia patients acute myeloid aml chronic cytogenetic patient cml leukaemia
19/59	Clinical Trials sub-cluster 59	patients coronary angina cad artery disease myocardial pectoris unstable group
19/60	Clinical Trials sub-cluster 60	patients neuropathy nerve sensory conduction peripheral motor polyneuropathy patient clinical
19/61	Clinical Trials sub-cluster 61	copd asthma patients airway asthmatic obstructive chronic pulmonary bronchial obstruction
19/62	Clinical Trials sub-cluster 62	pulmonary patients lung disease chest interstitial patient function hrct fibrosis
19/63	Clinical Trials sub-cluster 63	patients pituitary adrenal gh cortisol acth cushing hormone patient adenoma
19/64	Clinical Trials sub-cluster 64	patients lymphocyte lymphocytic disease peripheral cll cells patient cell normal
19/65	Clinical Trials sub-cluster 65	patients renal proteinuria glomerulonephritis nephropathy nephrotic glomerular iga disease anca
19/66	Clinical Trials sub-cluster 66	patients ct scan tomography computed pet patient findings disease fdg
19/67	Clinical Trials sub-cluster 67	patients neutrophil neutrophils periodontal periodontitis pmn chemotaxis monocytes chemotactic gingival
19/68	Clinical Trials sub-cluster 68	patients evoked potentials cerebellar ataxia somatosensory latency brainstem abnormal auditory
19/69	Clinical Trials sub-cluster 69	patients sickle transfusion thalassemia hb splenectomy cell anemia hemoglobin patient
19/70	Clinical Trials sub-cluster 70	bowel patients intestinal ibs small disease diarrhea obstruction gastrointestinal patient
19/71	Clinical Trials sub-cluster 71	brain patient injury matter damaged cerebral mri traumatic damage lesions
19/72	Clinical Trials sub-cluster 72	patients coagulation factor viii inhibitor dic hemophilia patient inhibitors vwf
19/73	Clinical Trials sub-cluster 73	patients visual retinal acuity optic macular vision patient retinitis field
19/74	Clinical Trials sub-cluster 74	urinary patients excretion urine renal tract patient normal creatinine disease
19/75	Clinical Trials sub-cluster 75	cerebral patients hemorrhage subarachnoid sah vasospasm intracranial patient intracerebral ich
19/76	Clinical Trials sub-cluster 76	patients iga igg complement igm immune serum levels c3 immunoglobulin
19/77	Clinical Trials sub-cluster 77	neurological patients neurologic poisoning symptoms patient disease clinical deficits manifestations
19/78	Clinical Trials sub-cluster 78	patients limb amputation vascular extremity patient claudication lower disease limbs
19/79	Clinical Trials sub-cluster 79	patients tube intubation patient laryngeal airway tracheal feeding tracheostomy tubes
19/80	Clinical Trials sub-cluster 80	patients glaucoma ocular uveitis cataract corneal patient lens angle contact
19/81	Clinical Trials sub-cluster 81	patients risk cardiovascular mortality ckd disease events ci death high
19/82	Clinical Trials sub-cluster 82	skin patients dermatitis atopic cutaneous patient lesions disease clinical treatment
19/83	Clinical Trials sub-cluster 83	patients myasthenia gravis lymphoma malignant patient elderly thymectomy pemphigus malignancy
19/84	Clinical Trials sub-cluster 84	patients allergic nasal reactions rhinitis allergy patient reaction ige hypersensitivity
19/85	Clinical Trials sub-cluster 85	patients joint knee hip joints patient shoulder arthroplasty tmj temporomandibular
19/86	Clinical Trials sub-cluster 86	patients creatinine renal magnesium serum clearance potassium digoxin pharmacokinetics patient
19/87	Clinical Trials sub-cluster 87	patients dystrophy muscular patient duchenne mutations dmd deletion mitochondrial myotonic
19/88	Clinical Trials sub-cluster 88	patients appendicitis testicular infertility ovarian sperm endometriosis patient laparoscopy acute
19/89	Clinical Trials sub-cluster 89	patients biopsy biopsies endometrial carcinoma patient cytology diagnosis specimens dysplasia
19/90	Clinical Trials sub-cluster 90	psoriasis patients treated patient psoriatic treating puva tuberculous therapy arthritis
19/91	Clinical Trials sub-cluster 91	schizophrenic patient psychotic leprosy chronic treatment schizophrenia geriatric schizophrenics neuroleptic
19/92	Clinical Trials sub-cluster 92	patient analgesia anesthesia anaesthesia obese epidural sedation controlled propofol intravenous
19/93	Clinical Trials sub-cluster 93	patients cervical cleft palate spine patient scoliosis lumbar denture edentulous
19/94	Clinical Trials sub-cluster 94	patients life patient quality qol psychological questionnaire fatigue physical scores
19/95	Clinical Trials sub-cluster 95	serum patients levels elevated disease level controls sil-2r normal healthy
19/96	Clinical Trials sub-cluster 96	patients fever patient bacteremia antibiotic antibiotics infection therapy abscess infections
19/97	Clinical Trials sub-cluster 97	patients psychiatric patient psychotherapy therapist borderline experience ocd analyst anxiety
19/98	Clinical Trials sub-cluster 98	patient patients satisfaction education doctor information consent doctors compliance staff
19/99	Clinical Trials sub-cluster 99	patient patients page jama safety rights privacy protection comatose preparing